APLS   $30.02  4.45% Market Closed After Close 30.1715 0.50%

Apellis Pharmaceuticals Inc

EMA (20): 2024-11-06 the price crossed up the moving average line and formed a short-term upside trend.

EMA (50): 2024-09-11 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (100): 2024-04-02 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

RSI: RSI indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's higher than the signal line and grows. These factors mean that the falling period is over. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

Trend Type flat and down
Power medium strength
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 2.20%
EMA (20) date of signal Nov. 6, 2024, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -23.27%
EMA (50) date of signal Sept. 11, 2024, 3 a.m.
EMA (100) Signals None
EMA (100) Yield 0.0
EMA (100) date of signal
RSI Signals bullish
RSI (14) Yield 0.0
RSI (14) date of signal Nov. 8, 2024, 3 a.m.
MACD Signals bullish reversal
MACD Yield 8.57%
MACD date of signal Oct. 11, 2024, 3 a.m.
Stochastic Signals bullish
Stochastic Yield 5.53%
Stochastic date of signal Nov. 1, 2024, 3 a.m.
Updated Nov. 9, 2024, 11 p.m.